During Monday’s Current trade, Shares of Forest City Enterprises, Inc. (NYSE:FCE.A), lost -0.39% to $20.63.
Forest City Enterprises, Inc. (NYSE:FCEA ) declared that its Board of Directors has set the date of a special meeting of shareholders in connection with the company’s formerly declared plan to convert to a real estate investment trust (“REIT”). The meeting will be held on October 15, 2015, at 2:00 p.m., Eastern Time. Shareholders of record as of the close of business on August 31, 2015, will be entitled to receive notice of and to vote at the meeting.
Forest City Enterprises, Inc. acquires, owns, develops, and manages commercial and residential real estate and land in the United States. The company’s Commercial group acquires, owns, develops, and operates regional malls, specialty/urban retail centers, office and life science buildings, and mixed-use projects, in addition to operates Barclays Center, a sports and entertainment arena located in Brooklyn, New York. Its Residential group acquires, owns, develops, and operates residential rental properties, counting upscale and middle-market apartments and adaptive re-use developments, in addition to develops and manages military family housing.
Shares of Molina Healthcare, Inc. (NYSE:MOH), declined -0.32% to $80.49, during its current trading session.
Molina Healthcare, Inc. (MOH) declared that it will host an Investor Day meeting at the Le Parker Meridien Hotel in New York City on Thursday, September 17, 2015, from 12:30 p.m. to 4:30 p.m. Eastern Time. The Company will webcast the presentations offered by its administration team, which will be followed by question-and-answer sessions. A 30-day online replay of the Investor Day meeting will be accessible about one hour following the conclusion of the live webcast. A link to this webcast can be found on the Company’s website at molinahealthcare.com.
Molina Healthcare, Inc. provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program. The company operates through two segments, Health Plans and Molina Medicaid Solutions. The Health Plans segment operates health plans in 11 states. As of December 31, 2014, this segment served about 2.6 million members who were eligible for Medicaid, Medicare, and other government-sponsored health care programs.
BioDelivery Sciences International, Inc. (NASDAQ:BDSI), during its Monday’s current trading session decreased -3.37% to $6.80.
BioDelivery Sciences International, Inc. (BDSI) declared that the company will present at two forthcoming healthcare conferences:
6th Annual Credit Suisse Small & Mid Cap Conference
Date: Wednesday, September 16
Location: Waldorf Astoria, New York City
Presentation Time: 10:10 AM Eastern Time
Ladenburg Thalmann 2015 Healthcare Conference
Date: Tuesday, September 29
Location: Sofitel New York, New York City
Presentation Time: 10:00 AM Eastern Time
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products principally in the areas of pain administration and addiction. The company provides its products based on its patented BioErodible MucoAdhesive (BEMA) drug delivery technology, which comprises of a small, bi-layered erodible polymer film for application to the buccal mucosa.
Finally, Extreme Netoperates, Inc (NASDAQ:EXTR), gained 2.73%, to $3.39.
Extreme Netoperates, Inc. (EXTR) declared it has been positioned the furthest by Gartner, Inc. in the “Visionaries” quadrant of the September 2015 Magic Quadrant for Wired and Wireless LAN Access Infrastructure for “Completeness of Vision.
According to Gartner, “a vendor in the Visionaries quadrant demonstrates an ability to enhance features in its offering to provide a unique and differentiated approach to the market. Visionaries will have innovated in one or more of the key areas of access layer technologies within the enterprise (for example, convergence, security, administration or operational efficiency). The ability to apply differentiating functionality across the entire access layer will affect their position.”
Buprenorphine HCl buccal film is being developed under the proprietary name BELBUCA™ (buprenorphine HCl) buccal film and is presently under review by the U.S. Food and Drug Administration (FDA) for use in patients with pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. The PDUFA action date is in October 2015.
Extreme Networks, Inc., together with its subsidiaries, provides wired and wireless network infrastructure equipment, software, and services for enterprises, data centers, and service providers. The company offers Black Diamond products, which deliver modular or chassis-based Ethernet connectivity solutions that have a range of management and line cards allowing customers to configure and re-purpose the systems; and Summit product family of stackable Ethernet switching systems, which provide a range of connection speeds, various physical presentations, and options to deliver PoE or unpowered standard Ethernet ports. It also provides IdentiFi family of wireless access points that offer both indoor and outdoor 802.11a/b/g/n/ac access points; NetSight management software system, which manages and automates the network through a single interface; and network access control (NAC) and MobileIAM products that provide pre-connect and post-connect network access control solutions for wired and wireless LAN and VPN users. In addition, the company offers Purview, a network-powered application analytics and optimization solution. Further, it provides Software-Defined Networking solution with network management, network access control, application analytics, and wireless controller technology facilities. Additionally, it offers professional and training services; and support services for end-users, resellers, and distributors. It serves businesses, hospitals, hotels, universities, sports venues, telecommunications companies, and government agencies.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
